在注射纤维素缩物后,血栓凝固度的剂量依赖性变化:回顾性观察研究
Stanislaw Vander Zwaag1, Imre Kukel1, Kinga Towarek-Nocon2
1Insitute of Cardiac Anesthesiology, Faculty of Medicine and Heart Center, TUD Dresden University of Technology, Dresden, Germany.
Journal of cardiothoracic and vascular anesthesia
|August 22, 2025
概括
纤维素缩剂的剂量有效预测心脏手术患者的凝块强度变化. 基于体重的剂量与凝块稳定性相关 (A5),有助于控制低纤维素生成症.
科学领域:
- 麻醉学
- 血液学
- 护理点诊断
背景情况:
- 粘性弹性诊断在心脏手术中至关重要.
- FIBTEM测定指南建议目标最大的凝块密度以尽量减少出血.
- 实现这些目标的最佳纤维素度 (FC) 剂量尚未确定.
研究的目的:
- 在心脏手术患者中分析5分钟后FC和凝块强度之间的剂量反应关系 (A5).
- 评估A5的术后低纤维素生成血的预测值.
主要方法:
- 在高等学术心脏病医院进行了回顾性观察性研究.
- 包括2022年5月至2024年8月期间的180名心脏手术患者.
- 分析了手术内旋转血栓测量 (ROTEM) 数据和凝血因子的使用情况.
主要成果:
- 线性回归显示了基于体重的FC剂量和A5变化之间的强烈相关性.
- 每增加10毫克/公斤,A5增加1.021.37毫米,取决于重量基础 (总体,理想,瘦).
- A5 ≤12 mm 准确预测的低纤维化血症 (敏感度为77%,特异性为94%).
结论:
- 基于体重的纤维素剂量可以预测A5的平均变化.
- 总体体重,理想体重和瘦身体重的相关系数与FC剂量相比较.
- 在这一群体中,A5测量是低纤维化血症的有价值预测指标.
相关概念视频
Clot Retraction and Fibrinolysis
6.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K


